Condition: Moderate to Severe Asthma · Sponsor: Washington University School of Medicine
Purpose: This study aims to improve asthma care by helping clinicians at community health centers prescribe a guideline-recommended treatment called SMART (Single Maintenance and Reliever Therapy). The investigators will provide training and resources to clinicians, give feedback on prescribing patterns, and offer educational tools for patients and providers. The investigators will roll out these resources in stages across clinics. The study will measure how well the program helps clinicians prescribe SMART therapy and whether it reduces asthma exacerbations in patients.
This description comes directly from the study's public registry record.
James Krings, MD MSCI · 3143769452 · kringsj@wustl.edu
Krutika Chauhan, MBBS MPH · 3143769452 · c.krutika@wustl.edu
Always discuss trial participation with your own doctor first.
| Affinia healthcare, 2220 Lemp Ave | St Louis, Missouri, United States | Not Yet Recruiting |
| Affinia healthcare, 1717 Biddle Street | St Louis, Missouri, United States | Not Yet Recruiting |
| Affinia healthcare, 4414 North Florissant Avenue | St Louis, Missouri, United States | Recruiting |
| Family Care Heath Center, 4352 Manchester Ave | St Louis, Missouri, United States | Not Yet Recruiting |
| Washington University in St. Louis School of Medicine | St Louis, Missouri, United States | Recruiting |
| Family Care Heath Center, 401 Holly Hills Ave | St Louis, Missouri, United States | Not Yet Recruiting |
| Affinia healthcare, 3396 Pershall Road, | St Louis, Missouri, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07241117